WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017067527) BENZOBICYCLON COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Considered void 2018-03-27 01:00:00.0


Pub. No.:    WO/2017/067527    International Application No.:    PCT/CN2016/108053
Publication Date: 27.04.2017 International Filing Date: 30.11.2016
IPC:
C07D 413/12 (2006.01), A61K 31/33 (2006.01), A61K 31/343 (2006.01), A61P 11/00 (2006.01), A61P 25/00 (2006.01), A61P 37/00 (2006.01), A61P 25/16 (2006.01), A61P 25/18 (2006.01), A61P 25/22 (2006.01), A61P 25/24 (2006.01)
Applicants: BEIJING KONRUNS BIOTECHNOLOGY CO., LTD. [CN/CN]; Room A710, Building A, No.9 Shangdi 3rd Street Haidian District, Beijing 100085 (CN)
Inventors: WANG, Xijuan; (CN).
LI, Jingrong; (CN)
Agent: CN-KNOWHOW INTELLECTUAL PROPERTY AGENT LIMITED; 18th Floor, Tower B, CEC Plaza No. 3 Dan Ling Street, Haidian District Beijing 100080 (CN)
Priority Data:
201510685090.7 20.10.2015 CN
Title (EN) BENZOBICYCLON COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND USES THEREOF
(FR) COMPOSÉ BENZOBICYCLONE, SELS PHARMACEUTIQUEMENT ACCEPTABLES ET COMPOSITIONS PHARMACEUTIQUES CORRESPONDANTS ET UTILISATIONS CORRESPONDANTES
(ZH) 一种苯并双环化合物或其药学上可接受的盐、药物组合物及其应用
Abstract: front page image
(EN)The present invention relates to a benzobicyclon compound as presented in formula (I) or pharmaceutically acceptable salts thereof. Also disclosed are a preparation method for said compound, pharmaceutical compositions containing the benzobicyclon compound, and uses thereof. The compound is a phosphodiesterase (for example, PDE4) inhibitor, and can be used for the treatment of diseases caused by phosphodiesterase activity abnormality, such as chronic obstructive pulmonary diseases (COPDs).
(FR)La présente invention concerne un composé benzobicyclone tel que représenté dans la formule (I) ou des sels pharmaceutiquement acceptables correspondants. L'invention concerne également un procédé de préparation pour ledit composé, des compositions pharmaceutiques contenant le composé benzobicyclone et des utilisations correspondantes. Le composé est un inhibiteur de la phosphodiestérase (par exemple PDE4) et peut être utilisé pour le traitement de maladies provoquées par une anomalie de l'activité de la phosphodiestérase, telle que les bronchopneumopathies chroniques obstructives (BPCO).
(ZH)本发明涉及一类如式(I)所示的苯并双环化合物或其在药学上可接受的盐,同时还公开了该化合物的制备方法、包含所述苯并双环化合物的药物组合物及其应用。这类化合物是磷酸二酯酶(例如PDE4)抑制剂,可用于治疗因磷酸二酯酶活性异常所引起的疾病,例如慢性阻塞性肺疾病(COPD)等。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)